Winning: How Novartis Ensured a Stable Supply of Medicines During COVID

September 18, 2020

Join Steffen Lang, Ph.D., Global Head of Novartis Technical Operations as he discusses how Novartis was able to ensure that a stable supply of medicines was available throughout the COVID-19 pandemic. Novartis Technical Operations (NTO), the global manufacturing and supply network of Novartis, has long had in place a business continuity and supply risk management framework to prepare for unexpected situations like COVID-19. Lang attributes five factors that were key to Novartis’ efforts:

  • Supply readiness
  • Supply Diversity
  • Digital Readiness
  • Supporting People

Read the full article here.


Share This Story!